Is vTv Therapeutics Inc. (VTVT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.1% / 30% | 26.4% / 30% | 0.0% / 30% | 153.88% / 5% | ✗ NOT HALAL |
| DJIM | 0.1% / 33% | 26.4% / 33% | 0.0% / 33% | 153.88% / 5% | ✗ NOT HALAL |
| MSCI | 0.4% / 33% | 96.0% / 33% | 0.2% / 33% | 153.88% / 5% | ✗ NOT HALAL |
| S&P | 0.1% / 33% | 26.4% / 33% | 0.0% / 33% | 153.88% / 5% | ✗ NOT HALAL |
| FTSE | 0.4% / 33% | 96.0% / 33% | 0.2% / 50% | 153.88% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -78.9% | |
| Return on Assets (ROA) | -32.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$25M |
| Free Cash Flow | -$25M |
| Total Debt | $0 |
| Current Ratio | 13.5 |
| Total Assets | $90M |
Price & Trading
| Last Close | $37.80 |
| 50-Day MA | $35.66 |
| 200-Day MA | $26.12 |
| Avg Volume | 37K |
| Beta | 0.4 |
|
52-Week Range
$14.00
| |
About vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is vTv Therapeutics Inc. (VTVT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), vTv Therapeutics Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is vTv Therapeutics Inc.'s debt ratio?
vTv Therapeutics Inc.'s debt ratio is 0.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.4%.
What are vTv Therapeutics Inc.'s key financial metrics?
vTv Therapeutics Inc. has a market capitalization of $152M. Return on equity stands at -78.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.